arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Beta Bionics, Inc.

BBNX Health Care Medical/Dental Instruments
$19.36
▲ +5.2% Today
as of Oct 23, 10:00 ET
Last 30 days +15.84% Sep 14 → Oct 23
$15.83 $17.71 $19.58 $21.45 $23.33 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$18.40
High
$19.38
Low
$18.23
Volume
$685,199
Avg Vol
$1M
Mkt Cap
$952M
P/E (TTM)
—
Beta
—
52w High
$32.71
52w Low
$8.80
Div Yield
—
Shares Out
$45M

Recent Press Releases & News last 60 days · 25 items

Oct 20 · 13:00 Zacks
Beta Bionics, Inc. (BBNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Oct 12 · 11:23 MT Newswires
Jefferies & Co Initiates Coverage on Beta Bionics With Buy Rating, $30 Price Target
Oct 9 · 00:22 Simply Wall St.
Beta Bionics (BBNX) Stock Fair Value Rises After Mint Clearance And Analyst Target Changes
▸ Show all 25 press releases & news Free account →

BBNX earnings at a glance

Beta Bionics, Inc. (BBNX) is scheduled to report earnings on Tuesday, October 27, 2026 after the market closes — in 4 days. Analysts expect earnings per share of -$0.53, compared with -$0.33 in the same quarter last year (-61%). The options market is pricing a move of about ±11.0% after the report, a range of roughly $17.23 to $21.49 from today's $19.36. Over its last 6 reports the stock rose the next day 3 times and fell 3, moving ±10.1% on average; after the most recent report on Jul 29, 2026 it moved -5.9%. That means options currently expect about the same movement than BBNX has typically delivered. BBNX beat the consensus EPS estimate in 5 of its last 6 reported quarters. Implied volatility is currently 83%. The share price of $19.36 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$8.80
$33
44% of range
Avg surprise (last 6)
+16.5%
Avg reaction (last 6)
+7.0%
50% positive
Latest IV / EM
83%
EM ±11.0% · $18 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.37$-1.85$-1.33$-0.82$-0.30 Actual $-2.07Actual $-2.37Actual $-1.46Actual $-0.52Est $-0.51Actual $-0.39Est $-0.51Actual $-0.33Est $-0.45Actual $-0.30Est $-0.42Actual $-0.49Est $-0.53Actual $-0.53Est $-0.62 MarJunSepMar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$-29M$-13M$2M$18M$34M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Jul 29, 2026Jun/2026 $-0.53 $-0.62 +14.5% -59.0% -5.9% earnings
Tue Apr 21, 20268K 2026-04-21 $-0.49 $-0.53 +7.5% — -0.6% earnings
Tue Feb 17, 20268K 2026-02-17 $-0.30 $-0.42 +28.6% — -2.6% earnings
Tue Oct 28, 2025Sep/2025 $-0.33 $-0.45 +26.7% — +10.3% earnings
Tue Jul 29, 2025Jun/2025 $-0.39 $-0.51 +23.5% — +14.3% earnings
Tue May 6, 2025Mar/2025 $-0.52 $-0.51 -2.0% — +26.6% earnings
Mon Sep 30, 2024Sep 2024 $-1.46 — — — — financials
Sun Jun 30, 2024Jun 2024 $-2.37 — — — — financials
Sun Mar 31, 2024Mar 2024 $-2.07 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Oct 27, 2026Sep/2026AMC -$0.53-$0.33 -60.6%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$32M$28M—$27M$23M$18M—$17M
Cost of revenue$13M$11M—$12M$11M$9M—$8M
Gross profit$19M$16M—$15M$13M$9M—$9M
Operating income$-26M$-24M—$-17M$-20M$-19M—$-11M
Net income$-23M$-22M—$-14M$-17M$-29M—$-10M
EPS (diluted)$-0.53$-0.49—$-0.33$-0.39$-0.93—$-1.46

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$44M$30M$32M$38M$35M$42M$30M$17M
Inventory$24M$24M$22M$20M$17M$16M$13M—
Total current assets$231M$248M$268M$270M$286M$262M$133M—
Total assets$292M$304M$329M$330M$330M$338M$150M—
Long-term debt————————
Total liabilities$36M$33M$41M$35M$28M$24M$74M—
Total equity$256M$271M$288M$295M$302M$314M$-245M$-229M

Implied volatility — last 90 days

46%266%486%706%925% Jun 07 — IV 265% · EM ±36.7%Jun 08 — IV 292% · EM ±38.5%Jun 17 — IV 926% · EM ±38.7%Jun 19 — IV 118% · EM ±26.1%Jun 22 — IV 182% · EM ±38.0%Jun 23 — IV 182% · EM ±37.3%Jun 24 — IV 144% · EM ±28.9%Jun 25 — IV 201% · EM ±39.3%Jun 26 — IV 161% · EM ±30.8%Jun 29 — IV 161% · EM ±28.5%Jun 30 — IV 215% · EM ±37.1%Jul 01 — IV 194% · EM ±32.3%Jul 02 — IV 188% · EM ±30.4%Jul 03 — IV 195% · EM ±30.4%Jul 06 — IV 220% · EM ±30.5%Jul 08 — IV 128% · EM ±16.1%Jul 09 — IV 268% · EM ±31.6%Jul 10 — IV 271% · EM ±29.9%Jul 13 — IV 359% · EM ±29.9%Jul 20 — IV 121% · EM ±28.6%Jul 21 — IV 104% · EM ±24.3%Jul 22 — IV 106% · EM ±24.2%Jul 23 — IV 142% · EM ±31.9%Jul 24 — IV 154% · EM ±34.1%Jul 27 — IV 162% · EM ±33.8%Jul 28 — IV 158% · EM ±32.3%Jul 29 — IV 166% · EM ±33.3%Jul 30 — IV 182% · EM ±35.7%Jul 31 — IV 216% · EM ±41.3%Aug 04 — IV 133% · EM ±22.8%Aug 06 — IV 223% · EM ±36.1%Aug 07 — IV 228% · EM ±35.7%Aug 10 — IV 225% · EM ±31.1%Aug 11 — IV 218% · EM ±28.8%Aug 12 — IV 58% · EM ±7.2%Aug 14 — IV 52% · EM ±5.7%Aug 18 — IV 194% · EM ±14.1%Aug 19 — IV 97% · EM ±5.7%Aug 20 — IV 596% · EM ±24.9%Aug 24 — IV 105% · EM ±21.9%Aug 25 — IV 88% · EM ±18.0%Aug 26 — IV 47% · EM ±9.3%Aug 27 — IV 102% · EM ±20.0%Aug 28 — IV 101% · EM ±19.4%Aug 31 — IV 122% · EM ±21.6%Sep 01 — IV 111% · EM ±19.1%Sep 02 — IV 84% · EM ±14.0%Sep 03 — IV 102% · EM ±16.6%Sep 04 — IV 63% · EM ±9.8%Sep 07 — IV 71% · EM ±9.8%Sep 08 — IV 119% · EM ±15.8%Sep 09 — IV 123% · EM ±15.4%Sep 11 — IV 194% · EM ±21.4%Sep 15 — IV 317% · EM ±22.9%Sep 16 — IV 363% · EM ±21.4%Sep 17 — IV 386% · EM ±16.1%Sep 21 — IV 116% · EM ±24.3%Sep 22 — IV 112% · EM ±23.0%Sep 23 — IV 88% · EM ±17.6%Sep 24 — IV 107% · EM ±21.0%Sep 25 — IV 107% · EM ±20.5%Sep 28 — IV 86% · EM ±15.2%Sep 29 — IV 117% · EM ±20.1%Sep 30 — IV 144% · EM ±24.0%Oct 01 — IV 154% · EM ±24.9%Oct 02 — IV 155% · EM ±24.3%Oct 05 — IV 103% · EM ±14.3%Oct 06 — IV 83% · EM ±11.0%

Sector peers

IART
Integra LifeSciences Holdings Corporation
$1.0B $12.17+2.8%
PRCT
PROCEPT BioRobotics Corporation
$1.0B $19.82+8.5%
AORT
Artivion, Inc.
$1.1B $23.86+4.2%
BVS
Bioventus Inc.
$1.1B $15.07+5.8%
SIBN
SI-BONE, Inc.
$825M $21.33+2.5%
IRMD
iRadimed Corporation
$1.1B $87.61-0.2%

BBNX earnings FAQ

When is BBNX's next earnings date?

Beta Bionics, Inc. is expected to report on October 27, 2026, after the market closes.

What is BBNX's expected move for earnings?

Options currently price a move of about ±11.0%, or $2.13 per share either way from $19.36.

How does BBNX stock usually react to earnings?

Across the last 6 reports the average next-day move was ±10.1%, up 3 times and down 3 times.

What EPS are analysts expecting from Beta Bionics, Inc.?

The consensus estimate is -$0.53 per share, versus -$0.33 a year ago.

What is BBNX's implied volatility?

BBNX's at-the-money implied volatility is about 83% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in